glp 1 alcohol cessation GLP-1 Agonists for Use Disorder: UK Evidence and Guidance Ozempic and Other GLP-1 Drugs

Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al

Since the first IGF-1 radioimmunoassay in 1977, many methods for detecting IGF-1 have been introduced, including radioimmunoassay, ELISA, immuno-chemoluminescence, and mass spectrometry-based assays

The response from Oddway was practical and professional, which helped us complete internal approval faster

It reduces systemic inflammation, which may make some patients feel less bloated, but this is not the same as losing body fat

Similar to other diabetes medicines, taking metformin can cause hypoglycemia (low blood sugar levels)

Based on my experience and conversations with other athletes, here is a decision framework: Microdosing may be right if you: Only need to lose 3-8kg to reach your target race weight Train at high volume (10+ hours/week) and cannot afford to compromise fueling Have a history of GI sensitivity during exercise Are preparing for a specific race and cannot risk GI disruption Want to use GLP-1 as a tool alongside an already-disciplined nutrition plan Standard dosing may be more appropriate if you: Have significant weight to lose (15kg+) and are not currently in peak training Are in an off-season or base-building phase with lower fueling demands Have tried microdosing without meaningful results after 8-12 weeks Have metabolic health concerns (pre-diabetes, insulin resistance) that require therapeutic doses The key principle: find the minimum effective dose for your situation